.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Faisal Mohammad Amin

Vorsitz

08.12.2022
17:25 – 18:55
Scientific session
The interictal state of headache
Strauss 1

Invited speaker

09.12.2022
13:15 – 13:30 15 Min. 0 Min.
Invited lecture
Propranolol

Weitere Beteiligungen

08.12.2022
16:20 – 16:25 3 Min. 2 Min.
ePoster
P53
Use of non-pharmacological therapies in individuals with migraine eligible for treatment with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP)-signaling: a single-center cross-sectional observational study
CGRP inhibitors in the clinic, Migraine
08.12.2022
16:35 – 16:40 3 Min. 2 Min.
ePoster
P20
Cluster Headache – The Worst Possible Pain on YouTube
Cluster headache
09.12.2022
15:40 – 15:45 3 Min. 2 Min.
ePoster
P244
Interest in headache and other neurological subspecialties among neurology residents in Denmark: a nationwide survey
Epidemiology, Guidelines in headache
09.12.2022
16:15 – 16:20 3 Min. 2 Min.
ePoster
P266
Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study
CGRP inhibitors in the clinic, Migraine
09.12.2022
16:35 – 16:40 3 Min. 2 Min.
ePoster
P270
Past Preventive Migraine Treatment in Patients Initiating Fremanezumab in Clinical Practice: Interim Data from the PEARL Study
CGRP inhibitors in the clinic, Migraine